Menu
Not yet recruiting NCT07325617

Tracking AI/LLM Literacy and Knowledge in Urology Outpatients (TALK-U)

— Observational Health Information Seeking Behavior Anxiety

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Health Information Seeking Behavior, Anxiety. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Turkey (Türkiye)
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Official title

The TALK-U Study: Tracking AI/LLM Knowledge and Use in Urology Outpatients and Its Association With Anxiety, Satisfaction, and Health Awareness-A Cross-Sectional Study

Overview

This study is a one-time, questionnaire-based survey of adults attending a urology outpatient clinic. The investigators will examine whether patients who use AI chat tools based on large language models (LLMs), such as ChatGPT, before seeking care differ from non-users in (1) anxiety, (2) satisfaction with the clinic visit, and (3) awareness/understanding of their health condition. Participants who provide written informed consent will complete a brief survey during their clinic visit (about 5-7 minutes). The survey includes a standardized anxiety scale (GAD-7), visual analog scales (0-10) for anxiety before and after the visit, satisfaction, and disease awareness, as well as questions about AI/LLM knowledge and use. Treating clinicians will not have access to participants' survey responses, and participation will not affect clinical care.

Detailed description

The TALK-U study is a cross-sectional, observational survey conducted in the urology outpatient clinic of Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital. The primary exposure is self-reported AI/LLM knowledge and use for health information (e.g., whether participants have used ChatGPT or similar tools, frequency, awareness of AI, and purpose of use). The primary outcome is anxiety measured by GAD-7 at the time of the clinic encounter. Secondary outcomes include (i) anxiety assessed on a 0-10 visual analog scale before and after the visit, (ii) outpatient visit satisfaction (0-10 VAS), and (iii) perceived disease awareness/understanding (0-10 VAS).

Eligible adult first-time urology outpatients who can complete the survey independently and provide informed consent will be invited during a 2-month recruitment period. Analyses will compare outcomes between AI/LLM users and non-users and explore associations with age group (\<40, 40-60, \>60), education level, and urology subspecialty category. Data will be analyzed using appropriate parametric/nonparametric tests depending on distribution, with p \< 0.05 considered statistically significant.

Primary outcome measures

  • Pre-visit Anxiety (VAS 0-10) [Time frame: Day 0 (immediately before the outpatient visit)]
Secondary outcome measures (3)
  • Post-visit Anxiety (VAS 0-10) [Time frame: Day 0 (immediately after the outpatient visit)]
  • Visit Satisfaction (VAS 0-10) [Time frame: Day 0 (immediately after the outpatient visit)]
  • Disease Awareness/Understanding (VAS 0-10) [Time frame: Day 0 (during the outpatient clinic visit)]

Eligibility criteria

Inclusion criteria

  • Age 18 years or older
  • First-time visit to the Urology Outpatient Clinic
  • Able to read and write and complete the questionnaire independently
  • Able to provide written informed consent

Exclusion criteria

  • Age under 18 years
  • Insufficient literacy to understand and complete the questionnaire
  • Severe hearing or visual impairment, or a neurological/psychiatric condition that prevents understanding and completing the survey
  • Refusal or inability to provide informed consent
  • Currently under follow-up for a known urologic condition (i.e., not a first-time urology outpatient visit)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-control

Study locations

Turkey (Türkiye) · 1 center
  • Dr.Abdurrahman Yurtaslan Ankara Oncology Research and Training Hospital — Ankara

Identifiers

NCT: NCT07325617 · 2025-06/98

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗